Status:
RECRUITING
Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation
Lead Sponsor:
University of Colorado, Denver
Conditions:
Ovarian Cancer
Eligibility:
All Genders
Up to 30 years
Phase:
NA
Brief Summary
The "Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation" study is open to a subset of patients with disorders of sex development (DSD) which is associated with the risk of malignanc...
Detailed Description
Unlike the oncology population, in which patients have inherently normal fertility potential and reproductive function, individuals with DSD may have infertility caused by 1) abnormal gonadal developm...
Eligibility Criteria
Inclusion
- \< 30 years of age
- Individuals diagnosed with a disorder of sex development who have any risk for malignancy in their gonadal tissue and will have their gonads removed for a clinical indication
- Individuals diagnosed with a disorder of sex development who are at risk of primary ovarian insufficiency (POI) due to an underlying genetic condition
Exclusion
- Pregnancy
- Patients likely to retain inherent fertility and reproductive function
- Patients deemed high risk for perioperative complications
- Patients 7-17 years of age unable to provide assent (i.e. significant psychiatric problems/cognitive delay)
- Patients 18 and older unable to provide consent (i.e. significant psychiatric problems/cognitive delay)
Key Trial Info
Start Date :
August 16 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2031
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06518746
Start Date
August 16 2021
End Date
June 30 2031
Last Update
September 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado
Aurora, Colorado, United States, 80045